• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with COPD.

作者信息

Clini Enrico M, Beghé Bianca, Fabbri Leonardo M

出版信息

Am J Respir Crit Care Med. 2013 Apr 1;187(7):668-71. doi: 10.1164/rccm.201302-0230ed.

DOI:10.1164/rccm.201302-0230ed
PMID:23540872
Abstract
摘要

相似文献

1
Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with COPD.慢性阻塞性肺疾病只是慢性阻塞性肺疾病患者复杂多种疾病中的一个组成部分。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):668-71. doi: 10.1164/rccm.201302-0230ed.
2
Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.慢性阻塞性肺疾病（COPD）中客观确定的合并症：对肺康复结局的影响。
Eur Respir J. 2015 Aug;46(2):545-8. doi: 10.1183/09031936.00026215. Epub 2015 Jun 25.
3
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.基于验证性客观测量和全身炎症的慢性阻塞性肺疾病患者的共病群。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):728-35. doi: 10.1164/rccm.201209-1665OC.
4
Impact of Comorbidities on the Treatment of Chronic Obstructive Pulmonary Disease.合并症对慢性阻塞性肺疾病治疗的影响。
Am J Med. 2018 Sep;131(9S):23-29. doi: 10.1016/j.amjmed.2018.05.002. Epub 2018 May 17.
5
Systemic consequences of COPD.慢性阻塞性肺疾病的全身影响
Ther Adv Respir Dis. 2007 Oct;1(1):47-59. doi: 10.1177/1753465807082374.
6
[Chronic obstructive pulmonary disease and associated illnesses].[慢性阻塞性肺疾病及相关疾病]
Ter Arkh. 2008;80(8):45-50.
7
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.慢性阻塞性肺疾病作为一种具有全身影响的肺部疾病——临床影响、机制及早期干预潜力
COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531.
8
Comorbidities in Patients With Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation Outcomes.慢性阻塞性肺疾病患者的合并症与肺康复结局
J Cardiopulm Rehabil Prev. 2017 Jul;37(4):283-289. doi: 10.1097/HCR.0000000000000236.
9
[Cachexia in chronic pulmonary obstructive disease].[慢性阻塞性肺疾病中的恶病质]
Wiad Lek. 2006;59(1-2):84-8.
10
[Pathomechanism of cachexia in chronic obstructive pulmonary disease].[慢性阻塞性肺疾病恶病质的发病机制]
Wiad Lek. 2005;58(11-12):647-51.

引用本文的文献

1
Modelling of biological age in stable and acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病稳定期和急性加重期生物学年龄的建模
BMC Pulm Med. 2025 Aug 19;25(1):398. doi: 10.1186/s12890-025-03841-4.
2
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care.揭示 COPD 共病的驱动机制，以制定以患者为中心的整体护理方法。
Eur Respir Rev. 2021 Jun 1;30(160). doi: 10.1183/16000617.0041-2021. Print 2021 Jun 30.
3
Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis.
2019年冠状病毒病患者中合并症与危重症的关系比较：一项网状Meta分析
Infect Chemother. 2021 Mar;53(1):13-28. doi: 10.3947/ic.2020.0136.
4
Prevalence and Determinants of Mental Health among COPD Patients in a Population-Based Sample in Spain.西班牙基于人群样本的慢性阻塞性肺疾病患者心理健康状况的患病率及影响因素
J Clin Med. 2021 Jun 24;10(13):2786. doi: 10.3390/jcm10132786.
5
Risk Prediction for Arrhythmias by Heart Rate Deceleration Runs in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者心率减速力运行预测心律失常风险。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 17;15:585-593. doi: 10.2147/COPD.S234470. eCollection 2020.
6
Statins versus placebo for people with chronic obstructive pulmonary disease.他汀类药物与安慰剂用于慢性阻塞性肺疾病患者的比较。
Cochrane Database Syst Rev. 2019 Jul 31;7(7):CD011959. doi: 10.1002/14651858.CD011959.pub2.
7
Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging.慢性阻塞性肺疾病中的疾病特异性共病集群与加速衰老
J Clin Med. 2019 Apr 14;8(4):511. doi: 10.3390/jcm8040511.
8
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis.布地奈德鼻喷雾剂治疗对合并鼻炎的慢性阻塞性肺疾病患者的临床影响。
Int J Chron Obstruct Pulmon Dis. 2018 Jun 27;13:2025-2032. doi: 10.2147/COPD.S165857. eCollection 2018.
9
Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.使用电子鼻分析呼出挥发性有机化合物作为慢性阻塞性肺疾病严重程度指标的验证
Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1441-1448. doi: 10.2147/COPD.S159684. eCollection 2018.
10
The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG.慢性阻塞性肺疾病（COPD）患者合并症的患病率及其对基层医疗患者健康状况和COPD症状的影响：国际基层医疗呼吸组（IPCRG）一项“解锁”研究的方案
NPJ Prim Care Respir Med. 2016 Nov 17;26:16069. doi: 10.1038/npjpcrm.2016.69.